5MAPB

5MAPB, also known as 5-(2-methylaminopropyl)benzofuran, is a research chemical belonging to the substituted benzofuran class. It is structurally related to compounds like 5-APB and 5-EAPB. 5MAPB was first synthesized in the laboratory and has primarily been studied for its potential pharmacological properties. Its mechanism of action is thought to involve interactions with monoamine transporters, particularly serotonin, dopamine, and norepinephrine.

Research into 5MAPB has explored its effects in various in vitro and in vivo models. Studies have investigated its binding affinities and functional effects at different receptor and transporter sites. Like many psychoactive compounds, 5MAPB has a limited history of human use, and comprehensive clinical data is largely absent. Its legal status varies significantly by jurisdiction, with many countries classifying it as a controlled substance due to its psychoactive potential and lack of approved medical applications. Due to its status as a research chemical, its availability is generally restricted to scientific institutions and specialized chemical suppliers. Further research is needed to fully understand its pharmacological profile and potential risks.